Key Details
Price
$4.52Annual ROE
190.26%Beta
2.74Events Calendar
Next earnings date:
May 6, 2025Recent quarterly earnings:
Nov 4, 2024Recent annual earnings:
N/ANext ex-dividend date:
N/ARecent ex-dividend date:
N/ANext split:
N/ARecent split:
N/AAnalyst ratings
Recent major analysts updates
Mar 7, 25 HC Wainwright & Co.
BuyJan 30, 25 B. Riley Securities
BuyDec 17, 24 HC Wainwright & Co.
BuyDec 16, 24 Jefferies
BuySep 24, 24 Morgan Stanley
Equal-WeightSep 3, 24 Jefferies
BuyAug 19, 24 Evercore ISI Group
OutperformAug 12, 24 HC Wainwright & Co.
BuyAug 9, 24 Wedbush
OutperformMay 7, 24 HC Wainwright & Co.
BuyMarket Data
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Price
Market cap
Technical
Dividend
Foghorn Therapeutics doesn't have historical dividend data
Profitability
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Revenue
Profit
EPS
ROA & ROE
EBIT & EBITDA
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PE Ratio
PB Ratio
PS Ratio
Enterprise value
EV/EBITDA
Financial Health
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Leverage
Risk & Stability
Balance Sheet
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Assets
Equity
Liabilities
Debt
Expenses
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cash Flow
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cashflow Activities
Free CashFlow
CAPEX
Institutional Ownership
FAQ
- What is the ticker symbol for Foghorn Therapeutics?
- Does Foghorn Therapeutics pay dividends?
- What sector is Foghorn Therapeutics in?
- What industry is Foghorn Therapeutics in?
- What country is Foghorn Therapeutics based in?
- When did Foghorn Therapeutics go public?
- Is Foghorn Therapeutics in the S&P 500?
- Is Foghorn Therapeutics in the NASDAQ 100?
- Is Foghorn Therapeutics in the Dow Jones?
- When was Foghorn Therapeutics's last earnings report?
- When does Foghorn Therapeutics report earnings?
- Should I buy Foghorn Therapeutics stock now?
What is the ticker symbol for Foghorn Therapeutics?
The ticker symbol for Foghorn Therapeutics is NASDAQ:FHTX
Does Foghorn Therapeutics pay dividends?
No, Foghorn Therapeutics does not pay dividends
What sector is Foghorn Therapeutics in?
Foghorn Therapeutics is in the Healthcare sector
What industry is Foghorn Therapeutics in?
Foghorn Therapeutics is in the Biotechnology industry
What country is Foghorn Therapeutics based in?
Foghorn Therapeutics is headquartered in United States
When did Foghorn Therapeutics go public?
Foghorn Therapeutics's initial public offering (IPO) was on October 23, 2020
Is Foghorn Therapeutics in the S&P 500?
No, Foghorn Therapeutics is not included in the S&P 500 index
Is Foghorn Therapeutics in the NASDAQ 100?
No, Foghorn Therapeutics is not included in the NASDAQ 100 index
Is Foghorn Therapeutics in the Dow Jones?
No, Foghorn Therapeutics is not included in the Dow Jones index
When was Foghorn Therapeutics's last earnings report?
Foghorn Therapeutics's most recent earnings report was on Nov 4, 2024
When does Foghorn Therapeutics report earnings?
The next expected earnings date for Foghorn Therapeutics is May 6, 2025
Should I buy Foghorn Therapeutics stock now?
As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions